These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 31894861)

  • 1. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics.
    Moludi J; Maleki V; Jafari-Vayghyan H; Vaghef-Mehrabany E; Alizadeh M
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):927-939. PubMed ID: 31894861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke.
    Wu H; Chiou J
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary metabolism, the gut microbiome, and heart failure.
    Tang WHW; Li DY; Hazen SL
    Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.
    Yoo JY; Kim SS
    Nutrients; 2016 Mar; 8(3):173. PubMed ID: 26999199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in coronary artery disease: a friend or foe?
    Zhang B; Wang X; Xia R; Li C
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32352513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence meets function-microbiota and cardiovascular disease.
    Kim M; Huda MN; Bennett BJ
    Cardiovasc Res; 2022 Jan; 118(2):399-412. PubMed ID: 33537709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional Management of Metabolic Endotoxemia: A Clinical Review.
    Brown BI
    Altern Ther Health Med; 2017 Jul; 23(4):42-54. PubMed ID: 28646814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiota as a novel regulator of cardiovascular function and disease.
    Battson ML; Lee DM; Weir TL; Gentile CL
    J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota and cardiovascular disease risk: A scoping review.
    Scarmozzino F; Poli A; Visioli F
    Pharmacol Res; 2020 Sep; 159():104952. PubMed ID: 32492487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary heart disease and intestinal microbiota.
    Liu L; He X; Feng Y
    Coron Artery Dis; 2019 Aug; 30(5):384-389. PubMed ID: 31276455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases.
    Schiattarella GG; Sannino A; Esposito G; Perrino C
    Trends Cardiovasc Med; 2019 Apr; 29(3):141-147. PubMed ID: 30126689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome and osteoarthritis: New insights from animal and human studies.
    Tan TC; Chong TKY; Low AHL; Leung YY
    Int J Rheum Dis; 2021 Aug; 24(8):984-1003. PubMed ID: 33961348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
    Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
    Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
    Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the gut microbiome in cardiovascular and autoimmune diseases.
    Weis M
    Clin Sci (Lond); 2018 Nov; 132(22):2387-2389. PubMed ID: 30455339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
    Hsu CN; Hou CY; Hsu WH; Tain YL
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of functional food components on gut health.
    Wan MLY; Ling KH; El-Nezami H; Wang MF
    Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.